1 US Department of Health and Human Services. Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Rockville (MD): The Agency; 1993. Clinical Practice Guideline No.1. AHCPR Publication No. 92-0023. p.107.

2 Chlamydia trachomatis: Summary and conclusions of CMO's expert advisory group. Department of Health 1998. London.[section 1.1] [section 1.3] [section 3] [section 7]

3 1998 guidelines for treatment of sexually transmitted diseases. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998; 47: 1-111.[section 1.1] [section 1.3] [section 2] [section 4]

4 Davies HD, Wang EE. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination. CMAJ 1996; 154: 1631-44.[section 1.1] [section 1.3]

5 Hillis SD, Black C, Newhall J, Walsh C, Groseclose SL. New opportunities for Chlamydia prevention: applications of science to public health practice. Sex Transm Dis 1995; 22: 197-202.

6 Scottish Needs Assessment Programme: STI Services in Scotland. Glasgow: Scottish Forum for Public Health Medicine; 1997.

7 Moller BR, Ahrons S, Laurin J, Mardh PA. Pelvic infection after elective abortion associated with Chlamydia trachomatis. Obstet Gynecol 1982; 59: 210-3.[section 1] [section 3]

8 Qvigstad E, Skaug K, Jerve F, Vik IS, Ulstrup JC. Therapeutic abortion and Chlamydia trachomatis infection. Br J Ven Dis 1982; 58: 182-3.[section 1] [section 3]

9 Osser S, Persson K. Postabortal pelvic infection associated with Chlamydia trachomatis and the influence of humoral immunity. Am J Obstet Gynecol 1984; 150: 699-703.[section 1] [section 3]

10 Farley TM, Rosenburg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785-8.[section 1] [section 3]

11 Sprague DS, Bullough CHW, Rashid S, Roberts SAM. Screening for and treating Chlamydia trachomatis and Neisseria gonorrhoeae before contraceptive use and subsequent pelvic inflammatory infection. Br J Fam Plann 1990; 16: 54-8.[section 1] [section 3]

12 Genitourinary Medicine statistics Scotland. Year ending 31 March 1998. Information and Statistics Division, National Health Service in Scotland, Edinburgh 1999.[section 1] [section 3]

13 Addiss DG, Vaughn ML, Ludka D, Pfister J, Davis JP. Decreased prevalence of Chlamydia trachomatis infection associated with a selective screening program in family planning clinics in Wisconsin. Sex Transm Dis 1993; 20: 28-35.[section 1] [section 3.1] [section 3.2.2]

14 Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis Suppl 1990; 69: 157-67.

15 Humphreys JT, Henneberry JF, Rickard RS, Beebe JL. Cost-benefit analysis of selective screening criteria for Chlamydia trachomatis infection in women attending Colorado family planning clinics. Sex Transm Dis 1992; 19: 47-53.[section 1] [section 3.1] [section 3.2.2]

16 Herrmann B, Egger, M. Genital Chlamydia trachomatis infection in Uppsala County, Sweden, 1985-1993: declining rates for how much longer? Sex Transm Dis 1995; 22: 253-60.

17 Hillis SD, Nakashima A, Amsterdam L, Pfister J, Vaughn M, Addis D , et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspec 1995; 27: 108-11.

18 Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydia infections. The impact of community-wide testing. Sex Transm Dis 1997; 24: 169-75.

19 Skjeldestad FE, Nordbo SA Hadgu A. Sentinel surveillance of Chlamydia trachomatis infection in women terminating pregnancy. Genitourin Med 1997; 73: 29-32.

20 Egger M, Low N, Smith GD, Lindblom B, Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ 1998; 316: 1776-80.

21 FitzGerald MR, Welch J, Robinson AJ, Ahmed-Jushuf I. Clinical guidelines and standards for the management of uncomplicated genital chlamydial infection. Central Audit Group in Genitourinary Medicine. Int J STD AIDS 1998; 9: 253-62.

22 Templeton A. The prevention of pelvic infection Recommendations arising from the 31st RCOG Study Group edited by Allan Templeton. London RCOG Press 1996.

23 Stokes T, Schober P, Baker J, Bloor A, Kuncewicz I, Ogilivy J, et al. Evidence-based guidelines for the management of genital chlamydial infection in general practice. (Leicestershire Chlamydia Guidelines Group). Fam Pract 1999; 16: 269-77.

24 Black CM. Current Methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160-84.[section 2.1] [section 2.2]

25 Davies PO, Ridgway GL. The role of polymerase chain reaction and ligase chain reaction for the detection of Chlamydia trachomatis. Int J STD AIDS 1997; 8: 731-8.

26 Aronson MD, Phillips RS. Screening young men for chlamydia infection. JAMA 1993; 270: 209-8.

27 Ridgway GL, Mumtaz G, Robinson AJ, Franchini M, Carder C, Burczak J, et al. Comparison of the ligase chain reaction with cell culture for the diagnosis of Chlamydia trachomatis infection in women. J Clin Pathol 1996; 49: 116-9.

28 Grun L, Tassano-Smith J, Carder C, Johnson AM, Robinson A, Murray E, et al. Comparison of two methods of screening for genital chlamydia infection in women attending general practice: cross sectional survey. BMJ 1997; 315: 226-30.[section 2] [section 3]

29 Crotchfelt KA, Welsh LE, DeBonville D, Rosenstraus M, Quinn TC. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis in genitourinary specimens from men and women by a coamplification PCR assay. J Clin Microbiol 1997; 35: 1536-40.

30 Chernesky MA, Jang D, Sellors J, Luinstra K, Chong S, Castriciano S, et al. Urinary inhibitors of polymerase chain reaction and ligase chain reaction and testing of multiple specimens may contribute to lower assay sensitivities for diagnosing Chlamydia trachomatis infected women. Mol and Cell Probes 1996; 11: 243-9.

31 Quinn TC, Welsh L, Lentz A, Crotchfelt K, Zenilman J, Newhall J, et al. Diagnosis by AMPLICOR PCR of Chlamydia trachomatis infection in urine samples from women and men attending sexually transmitted disease clinics. J Clin Microbiol 1996; 34: 1401-6.[section 2.1] [section 2.2]

32 Buimer M, van Doornum GJ, Ching S, Peerbooms PG, Plier PK, Ram D, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implications for diagnostic testing and screening. J Clin Microbiol 1996; 34: 2395-400.

33 Pasternack R, Vuorinen P, Miettinen A. Evaluation of the Gen-Probe Chlamydia trachomatis transcription-mediated amplification assay with urine specimens from women. J Clin Microbiol 1997; 35: 676-8.

34 Crotchfelt KA, Pare B, Gaydos C, Quinn TC. Detection of Chlamydia trachomatis by the Gen-Probe AMPLIFIED Chlamydia trachomatis Assay (AMP CT) in urine specimens from men and women and endocervical specimens from women. J Clin Microbiol 1998; 36: 391-4.

35 Pasternack R, Vuorinen P, Miettinen A. Comparison of a transcription-mediated amplification assay and polymerase chain reaction for detection of Chlamydia trachomatis in first-void urine. Eur J Clin Microbiol Infect Dis 1999;18:142-4.

36 Ostergaard L, Andersen B, Olesen F, Moller JK. Efficacy of home sampling of Chlamydia trachomatis: randomised study. BMJ 1998; 317: 26-7.

37 Hook EW 3rd, Smith K, Mullen C, Stephens J, Rinehardt L, Pate MS, et al. Diagnosis of genitourinary Chlamydia trachomatis infections by using the ligase chain reaction on patient obtained vaginal swabs. J Clin Microbiol 1997; 35: 2133-5.

38 Chernesky MA, Jang D, Lee H, Burczak JD, Hu H, Sellors J, et al. Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. J Clin Microbiol 1994; 32: 2682-5.

39 Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W Jr, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993; 168: 1503-9.[section 3] [section 4]

40 Arya OP, Alergant CD, Annels EH, Carey PB, Ghosh AK, Goddard AD. Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse. Br J Ven Dis 1978; 54: 414-21.[section 3] [section 5]

41 Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334: 1362-6.[section 3.1] [section 3.2.2]

42 Oakeshott P, Chiverton S, Speight L, Bertrand J. Testing for cervical Chlamydia trachomatis infection in an inner city practice. Fam Pract 1992; 9: 421-4.[section 3.1] [section 3.2.2]

43 Cromer BA, Heald FP. Pelvic inflammatory disease associated with Neisseria gonorrhoeae and Chlamydia trachomatis: clinical correlates. Sex Transm Dis 1987; 14: 125-9.

44 Garland SM, Johnson B. Chlamydia trachomatis infections--the Royal Women's Hospital experience. Med J Aust 1989; 150: 174-7.

45 Malotte CK, Wiesmeier E, Gelineau KJ. Screening for chlamydia cervicitis in a sexually active university population. Am Public Health 1990; 80: 469-71.[section 3.1] [section 3.2.2]

46 Weinstock HS, Bolan GA, Kohn R, Balladares C, Back A, Oliva G. Chlamydia trachomatis infection in women: a need for universal screening in high prevalence populations? Am J Epidemiol 1992; 135: 41-7.[section 3.1] [section 3.2.2]

47 Cates W Jr, Wasserheit JM. Genital chlamydial infections: epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164: 1771-81.

48 Coste J, Laumon B, Bremond A, Collet P, Job-Spira N. Sexually transmitted diseases as major causes of ectopic pregnancy: results from a large case-control study in France. Fertil Steril 1994; 62: 289-95.

49 Padian NS, Washington AE. Pelvic Inflammatory Disease. A brief overview. Ann Epidemiol 1994; 4; 128-32.

50 Kamwendo F, Forslin L, Bodin L, Danielsson D. Programmes to reduce pelvic inflammatory disease - the Swedish experience. Lancet 1998; 351 (Suppl 3): 25-8.

51 Scott GR, Thompson C, Smith IW, Young H. Infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women with lower abdominal pain admitted to a gynaecology unit. Br J Obstet Gynaecol 1989; 96: 473-7.

52 Horner PJ, Hay PE, Thomas BJ, Renton AM, Taylor-Robinson D. The role of Chlamydia trachomatis in urethritis and urethral symptoms in women. Int J STD AIDS 1995;6: 31-4.

53 Krettek JE, Arkin SI, Chaisilwattana P, Monif GR. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting . Obstet Gynecol 1993; 81: 728-31.

54 Lindner LE, Geerling S, Nettum JA, Miller SL, Altman KH. Clinical characteristics of women with chlamydial cervicitis. J Reprod Med 1988; 33: 684-90.

55 Sellors JW, Pickard L, Gafni A, Goldsmith CH, Jang D, Mahony JB, et al. Effectiveness and efficiency of selective vs. universal screening for chlamydial infection in sexually active young women. Arch Intern Med 1992; 152: 1837-44.

56 Schachter J. Chlamydial infections (first of three parts). N Engl J Med 1978; 298: 428-35.

57 Dunlop EM, Vaughan-Jackson JD, Darougar S, Jones BR. Chlamydial infection. Incidence in 'non-specific' urethritis. Br J Vener Dis 1972; 48: 425-8.

58 Oriel JD, Reeve P, Powis P, Miller A, Nicol CS. Chlamydial infection. Isolation of Chlamydia from patients with non-specific genital infection. Br J Ven Dis 1972; 48: 429-36.

59 Zelin JM, Robinson AJ, Ridgway GL, Allason-Jones E, Williams P. Chlamydial urethritis in heterosexual men attending a genitourinary medicine clinic: prevalence, symptoms, condom usage and partner change. Int J STD AIDS 1995; 6: 27-30.

60 De Jong Z, Pontonnier F, Plante P, Gautier JR, Ioualalen A, Archambaud M, et al. The frequency of Chlamydia trachomatis in acute epididymitis. Br J Urol 1988; 62 :76-8.

61 Berger RE, Alexander ER, Harnisch JP, Paulsen CA, Monda GD, Ansell J, et al. Etiology, manifestations and therapy of acute epididymitis: prospective study of 50 cases. J Urol 1979; 121: 750-4.

62 Eley A, Oxley KM, Spencer RC, Kinghorn GR, Ben-Ahmeida ET, Potter CW. Detection of Chlamydia trachomatis by the polymerase chain reaction in young patients with acute epididymitis. Eur J Clin Microbiol Infect Dis 1992; 11: 620-3.

63 Keat AC, Thomas BJ, Taylor-Robinson D, Pegrum GD, Maini RN, Scott JT. Evidence of Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980; 39: 431-7.

64 Silveira LH, Gutierrez F, Scopelitis E, Cuellar ML, Citera G, Espinoza LR. Chlamydia-induced reactive arthritis. Rheum Dis Clin North Am 1993; 19: 351-62.

65 Taylor-Robinson D, Thomas BJ, Dixey J, Osborn MF, Furr PM, Keat AC. Evidence that Chlamydia trachomatis causes seronegative arthritis in women. Ann Rheum Dis 1988; 47: 295-9.

66 Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, et al. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med 1985; 102: 757-62.

67 Dalaker K, Gjonnaess H, Kvile G, Urnes A, Anestad G, Bergan T. Chlamydia trachomatis as a cause of acute perihepatitis associated with pelvic inflammatory disease. Br J Ven Dis. 1981; 57: 41-3.

68 Duthie SJ, Hobson D, Tait IA, Pratt BC, Lowe N, Sequeira PJL, et al. Morbidity after termination of pregnancy in first trimester. Genitourin Med 1987; 63:182-7.

69 Blackwell AL, Thomas PD, Wareham K, Emery SJ. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 1993; 342: 206-10.

70 Morton K, Regan L, Spring J, Houang E. A further look at infection at the time of therapeutic abortion. Eur J Obstet Gynecol Reprod Biol 1990; 37: 231-6.

71 Sorensen JL, Thranov I, Hoff G, Dirach J. Early - and late onset pelvic inflammatory disease among women with cervical Chlamydia trachomatis infection at the time of induced abortion - a follow up study. Infection 1994; 22: 242-6.

72 Skjeldestad FE, Tuveng JK, Solberg AG, Molne K, Dalen A, Buhaug H. Induced abortion: Chlamydia trachomatis and postabortal complications. A cost benefit analysis. Acta Obstet Gynecol Scand 1988; 67: 525-9.

73 Wein P, Kloss M, Garland SM. Postabortal pelvic sepsis in association with Chlamydia trachomatis. Aust N Z J Obstet Gynaecol 1990; 30: 347-50.

74 Penney GC, Thomson M, Norman J, McKenzie H, Vale L, Smith R, et al. A randomised comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol 1998; 105: 599-604.[section 3] [section 4]

75 Wood SM, Muscat I. Screening and treatment to prevent post abortion chlamydial pelvic infection. Lancet 1989; 2: 928-9.

76 Fish AN, Fairweather DV, Oriel JD, Ridgway GL. Chlamydia trachomatis infection in a gynaecology clinic population: identification of high-risk groups and the value of contact tracing. Eur J Obstet Reprod Biol 1989; 31: 67-74.

77 Hopwood J, Mallinson H, Jones I. There is more to a test than technology - evaluation of testing for chlamydia infection in a charitable sector termination service. Br J Fam Plann 1998; 23: 116-9.

78 Lloyd F, Liston WA, Smith IW, Macaulay AJ, Johnstone FD. Screening for Chlamydia trachomatis in women referred for legal abortion. J Obstet Gynaecol 1991; 11: 224-6.

79 Cohn M, Stewart P. Prevalence of potential pathogens in cervical canal before termination of pregnancy. BMJ 1992; 304: 1479.

80 Smith N, Nelson MR, Hammond J, Purkayastha S, Barton SE. Screening for lower genital tract infections in women presenting for termination of pregnancy. Int J STD AIDS 1994; 5: 212-3.

81 Tjiam KH, van Heijst BY, Polak-Vogelzang AA, Rothbarth PH, van Joost T, Stolz E. Sexually communicable micro-organisms in human semen samples to be used for artificial insemination by donor. Genitourin Med 1987; 63: 116-8.

82 Johnson AM, Wadsworth J, Wellings K, Field J. Who goes to sexually transmitted disease clinics? Results from a national population survey. Genitourin Med 1996; 72: 197-202.

83 Hay PE, Thomas BJ, Horner PJ, MacLeod E, Renton AM, Taylor-Robinson D. Chlamydia trachomatis in women: the more you look, the more you find. Genitourin Med 1994; 70: 97-100.

84 van-Duynhoven YT, van de Laar MJ, Fennema JS, van Doornum GJ, van der Hoek JA. Development and evaluation of screening strategies for Chlamydia trachomatis infections in an STD clinic. Genitourin Med 1995; 71: 375-81.[section 3.2.1] [section 3.2.2]

85 Labeja Acellam ET, Harris VG. A study to evaluate chlamydia screening in colposcopy clinics. J Obstet Gynaecol 1997; 17: 472-475.

86 Urban MA, Coury-Doniger PC, Reichman RC. Results of a screening program for Chlamydia trachomatis infection in men attending a sexually transmitted diseases clinic. Sex Transm Dis 1997; 24: 587-92.

87 Thompson C. Genital warts, trichomoniasis and other concurrent STIs in Scotland. Int J STD AIDS 1997; 8: 412.

88 Worm AM, Petersen CS. Transmission of chlamydial infections to sexual partners. Genitourin Med 1987; 63: 19-21.

89 Oskarsson T, Geirsson RT, Steingrimsson O, Thorarinsson H. Lower genital tract infection with Neisseria gonorrhoeae and Chlamydia trachomatis in women requesting induced abortion and in their sexual partners. Acta Obstet Gynecol Scand 1990; 69: 635-40.

90 Viscidi RP, Bobo L, Hook EW 3d, Quinn TC. Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction. J Infect Dis 1993; 168: 488-92.

91 Matondo P, Johnson I, Sivapalan S. Morbidity and disease prevalence in male and female sexual contacts of patients with genital chlamydia infection. Int J STD AIDS 1995; 6: 367-8.

92 Quinn TC, Gaydos C, Shepherd M, Bobo L, Hook EW 3rd, Viscidi R, et al. Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships. JAMA 1996; 276: 1737-42.

93 Kamwendo F, Johansson E, Moi H, Forslin L, Danielsson D. Gonorrhoea, genital chlamydial infection, and nonspecific urethritis in male partners of women hospitalised and treated for acute pelvic inflammatory disease. Sex Transm Dis 1993; 20: 143-6.

94 Grant JB, Costello CB, Sequeira PJ, Blacklock NJ The role of Chlamydia trachomatis in epididymitis. Br J Urol 1987; 60: 355-9.

95 Preece PM, Anderson JM, Thompson RG. Chlamydia trachomatis infection in infants: a prospective study. Arch Dis Child 1989; 64: 525-9.

96 Schachter J, Grossman M, Sweet RL, Holt J, Jordan C, Bishop EP. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255: 3374-7.

97 Rapoza PA, Quinn TC, Kiessling LA, Green WR, Taylor HR. Assessment of neonatal conjunctivitis with a direct immunofluorescent monoclonal antibody stain for Chlamydia. JAMA 1986; 255: 3369-73.

98 Buhaug H, Skjeldestad FE, Halvorsen LE, Dalen A. Should asymptomatic patients be tested for Chlamydia trachomatis in general practice? Br J Gen Pract 1990; 40:142-5.

99 Oakeshott P. Sexual health in teenagers. Lancet 1995; 346: 648-9.

100 Oakeshott P, Hay P. General practice update: Chlamydia infection in women. Br J Gen Pract 1995; 45: 615-20.

101 Smith JR, Murdoch J, Carrington D, Frew CE, Dougall AJ, MacKinnon H, et al. Prevalence of Chlamydia trachomatis infection in women having cervical smear tests. BMJ 1991; 302: 82-4.

102 Clay JC, Bowman CA. Controlling chlamydial infection. Genitourin Med 1996; 72:145.

103 Longhurst HJ, Flower N, Thomas BJ, Munday PE, Elder A, Constantinidou M, et al. A simple method for the detection of Chlamydia trachomatis infections in general practice. J R Coll Gen Pract 1987; 37: 255-6.

104 Kudesia G, Zadik PM, Ripley M. Chlamydia trachomatis infection in males attending general practitioners. Genitourin Med 1994; 70: 356.

105 Sin J, Gbolade BA, Russell A, Chandiok P, Kirkman RJE. Referral compliance of chlamydia positive patients from a family planning clinic. Br J Fam Plann 1996; 22: 155-6.

106 Hopwood J, Mallinson H, Agnew E. Chlamydia screening-should it be offered as a routine? Br J Fam Plann 1990; 16: 59-67.

107 Hopwood J, Mallinson H. Chlamydia testing in community clinics - a focus for accurate sexual health care. Br J Fam Plann 1995; 21: 87-90.

108 Macaulay ME, Riordan T, James JM, Leventhall PA, Morris EM, Neal BR, et al. A prospective study of genital infections in a family-planning clinic. 2. Chlamydia infection--the identification of a high-risk group. Epidemiol Infect 1990; 104: 55-61.

109 Murty J. Chlamydia: to screen or not to screen? One way to answer the question. Br J Fam Plann 1996; 22: 157-158.

110 James NJ, Wilson S, Hughes S. A pilot study to incorporate chlamydial testing in the management of women anticipating IUD insertion in community clinics. Br J Fam Plann 1997; 23: 16-19.

111 Stokes T. Screening for Chlamydia in general practice: a literature review and summary of the evidence. J Public Health Med 1997; 19: 222-32.

112 Han Y, Coles FB, Hipp S. Screening criteria for Chlamydia trachomatis in family planning clinics: accounting for prevalence and clients' characteristics. Fam Plann Perspect 1997; 29: 163-6.

113 Marrazzo JM, Fine D, Celum CL, DeLisle S, Handsfield HH. Selective screening for chlamydial infection in women: a comparison of three sets of criteria. Fam Plann Perspect 1997; 29: 158-62.

114 Marrazzo JM, White CL, Krekeler B, Celum CL, Lafferty WE, Stamm WE, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997; 127: 796-803.

115 Stergachis A, Scholes D, Heidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol 1993; 138: 143-53.

116 Weinstock H, Dean D, Bolan G. Chlamydia trachomatis infections. Infect Dis Clin North Am 1994; 8: 797-819.

117 Handsfield HH, Jasman LL, Roberts PL, Hanson VW, Kothenbeutel RL, Stamm WE. Criteria for selective screening for Chlamydia trachomatis infection in women attending family planning clinics. JAMA 1986; 255: 1730-4.

118 Ramstedt K, Forssman L, Giesecke J, Granath F. Risk factors for Chlamydia trachomatis infection in 6810 young women attending family planning clinics. Int J STD AIDS 1992; 3: 117-22.

119 Oriel JD, Ridgway GL, Tchamouroff S. Comparison of erythromycin stearate and oxytetracycline in the treatment of non-gonococcal urethritis: their efficacy against Chlamydia trachomatis. Scott Med J 1977; 22: 375-9.

120 Willcox RR. Erythromycin in the treatment of non-gonococcal urethritis. Br J Ven Dis 1968; 44: 157-9.

121 Holmes KK, Johnson DW, Floyd TM. Studies of venereal disease. 3. Double-blind comparison of tetracycline hydrochloride and placebo in treatment of nongonococcal urethritis. JAMA 1967; 202: 474-6.

122 Waugh MA, Nayyar KC. Triple tetracycline (Deteclo) in the treatment of chlamydial infection of the female genital tract. Br J Ven Dis 1977; 53: 98-9.

123 Oriel JD, Ridgway GL. Comparison of erythromycin and oxytetracycline in the treatment of cervical infection by Chlamydia trachomatis. J Infect 1980; 2: 259-62.

124 Scheibel JH, Kristensen JK, Hentzer B, Secher L, Ullman S, Verdich J, et al. Treatment of chlamydial urethritis in men and Chlamydia trachomatis-positive female partners: comparison of erythromycin and tetracycline in treatment courses of one week. Sex Transm Dis 1982; 9: 128-31.

125 Bowie WR, Manzon LM, Borrie-Hume, CJ, Fawcett, Jones HD. Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women. Am J Obstet Gynecol 1982; 142: 125-9.

126 Worm AM, Avnstorp C, Petersen CS. Erythromycin for four or seven days against Chlamydia trachomatis. Genitourin Med 1985; 61: 283.

127 Toomey KE, Barnes RC. Treatment of Chlamydia trachomatis genital infection. Rev Infect Dis 1990; 12: S645-55.[section 4.1] [section 4.2]

128 Shapiro LE, Knowles SR, Shear NH. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224-30.

129 Katz BP, Zwickl BW, Caine VA, Jones RB. Compliance with antibiotic therapy for Chlamydia trachomatis and Neisseria gonorrhoea. Sex Transm Dis 1992; 19: 351-4.

130 Brookoff D. Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease. South Med J 1994; 87: 1088-91.

131 Augenbraun M, Bachmann L, Wallace T, Dubouchet L, McCormack W, Hook EW 3rd. Compliance with doxycycline therapy in sexually transmitted diseases clinics. Sex Transm Dis 1998; 25: 1-4.

132 Hillis SD, Coles FB, Litchfield B, Black CM, Mojica B, Schmitt K, et al. Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis 1998; 25: 5-11.

133 Martin DH, Mroczkowski TF, Dalu ZA, McCarty J, Jones RB, Hopkins SJ, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Eng J Med 1992; 327: 921-5.

134 Nilsen A, Halsos A, Johansen A, Hansen E, Torud E, Moseng D, et al. A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males. Genitourin Med 1992; 68: 325-7.

135 Hammerschlag MR, Golden NH, Oh MK, Gelling M, Sturdevant M, Brown PR, et al. Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents. J Pediatr 1993; 122: 961-5.

136 Lauharanta J, Saarinen K, Mustonen MT, Happonen HP. Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males. J Antimicrob Chemother 1993; 31: Suppl 177-83.

137 Steingrimsson O, Olafsson JH, Thorarinsson H, Ryan RW, Johnson RB, Tilton RC. Single dose azithromycin treatment of gonorrhoea and infections caused by C. trachomatis and U. urealyticum in men. Sex Transm Dis 1994; 21: 43-6.

138 Stamm WE, Hicks CB, Martin DH, Leone P, Hook EW 3rd, Cooper RH, et al. Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study. JAMA 1995; 274: 545-9.

139 Thorpe EM Jr, Stamm WE, Hook EW 3rd, Gall SA, Jones RB, Henry K, et al. Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practices. Genitourin Med 1996; 72: 93-7.

140 Weber JT, Johnson RE. New treatments for Chlamydia trachomatis genital infection. Clin Infect Dis 1995; 20 Suppl1: S66-71.

141 Anon. Chlamydial STD treatment. Bandolier 1996; 28: 4-6.

142 Hooton TM, Batteiger BE, Judson FN, Spruance SL, Stamm WE. Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother 1992; 36: 1144-6.

143 Romanowski B, Talbot H, Stadnyk M, Kowalchuk P, Bowie WR. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Ann Intern Med 1993; 119: 16-22.

144 Brihmer C, Mardh PA, Kallings I, Osser S, Robech M, Sikstrom B, et al. Efficacy and safety of azithromycin versus lymecycline in the treatment of genital chlamydial infections in women. Scand J Infect Dis 1996; 28: 451-4.

145 Brocklehurst P, Rooney G. Interventions for treating Chlamydia trachomatis infection in pregnancy. In Neilson JP, Crowther CA, Hodnett ED, Hofmeyr GJ (editors.). Pregnancy and Childbirth module of The Cochrane Database of Systematic Reviews [updated 23 June 1998].

146 Turrentine MA, Newton ER. Amoxicillin or erythromycin for the treatment of antenatal chlamydial infection: a meta-analysis. Obstet Gynecol 1995; 86: 1021-5.

147 Bowie WR. In vitro activity of clavulanic acid, amoxicillin and ticarillin against Chlamydia trachomatis. Antimicrob Agents Chemother 1986; 29: 713-5.

148 Bell TA, Sandstrom IK, Eschenbach DA. Treatment of Chlamydia trachomatis in pregnancy with amoxicillin. In: Mardh PA, Holmes KK, Oriel JD, Piot P, Schachter J (editors). Chlamydial infections. Amesterdam: Elsvier Biomedical Press; 1982. p. 221-4.

149 Robertson DH, McMillan A, Young H. Prostatitis, Orchitis and Epididymitis. In: Clinical Practice in Sexually Transmitted Diseases. Churchill Livingstone; Edinburgh:1989. p. 244-253.

150 UK National Guidelines on sexually transmitted infections and closely related conditions. Sex Trans Inf 1999; 75(suppl1): S4-8

151 Radcliffe KW, Rowen D, Mercey DE, Mumtaz G, Ridgway GL, Robinson AJ, et al. Is a test of cure necessary following treatment for cervical infection with Chlamydia trachomatis? Genitourin Med 1990; 66: 444-6.

152 Alger LS, Lovchik JC. Comparative efficacy of clindamycin versus erythromycin in eradication of antenatal Chlamydia trachomatis. Am J Obstet Gynecol 1991; 165: 375-81.

153 Wijesurendra CS, White C, Sparks RA, Manuel AR. Is a test of cure necessary following treatment for cervical infection with Chlamydia trachomatis? Genitourin Med 1991; 67: 272.

154 White DJ, Mann CH, Matthews RS, Leemimg JG, Clay JC. The value of tests of cure following cervical chlamydial infection. Int J STD AIDS 1993; 4: 5-7.

155 Miller JM jnr. Efficacy and tolerance of single dose azithromycin for treatment of chlamydial cervicitis during pregnancy. Infect Dis Obstet Gynecol 1995/96; 3: 189-192.

156 Ali SM, Booth G, Monteiro E. Test of cure following treatment of genital Chlamydia trachomatis infection in male and female patients. Genitourin Med 1997; 73: 223.

157 Gaydos CA, Crotchfelt KA, Howell MR, Kralian S, Hauptman P, Quinn TC. Molecular amplification assays to detect chlamydial infections in urine specimens from high school female students and to monitor the persistence of chlamydial DNA after therapy. J Infect Dis 1998; 177: 417-24.

158 Svensson L, Mardh PA, Westrom L. Infertility after acute salpingitis with special reference to Chlamydia trachomatis. Fertil Steril 1983; 40:322-9.

159 Kroger F. Compliance strategies in a clinic for treatment of sexually transmitted diseases. Sex Transm Dis 1980; 7: 178-82[section 5] [section 6]

160 Oxman AD, Scott EA, Sellors JW, Clarke JH, Millson ME, Rasooly I, et al. Partner notification for sexually transmitted diseases: an overview of the evidence. Can J Public Health 1994; 85(suppl1): S41-47.

161 Millson ME, Rasooly I, Scott EA, Oxman AD, Frank JW, Sellors JW, et al. Partner notification for sexually transmitted diseases: proposed practice guidelines. Can J Public Health 1994; 85 (Suppl 1): S53-55.

162 Andersen B, Østergaard L, Møller JK, Olesen F. Home sampling versus conventional contact tracing for detecting Chlamydia trachomatis infection in male partners of infected women: randomised study. BMJ 1998: 316: 350-1.

163 Clinical Guidelines and Standards for Genital Chlamydia Infection - Central Audit Group in Genitourin Med. Health Education Authority. London. 1998.

164 Bryan AD, Aiken LS, West SG. Increasing condom use: evaluation of a theory-based intervention to prevent sexually transmitted diseases in young women. Health Psychol 1996; 15: 371-82.

165 Orr DP, Langefeld CD, Katz BP, Caine VA. Behavioural intervention to increase condom use among high-risk female adolescents. J Pediatr 1996; 128: 288-95.

166 Smith PB, Weinman ML, Parrilli J. The role of condom motivation education in the reduction of new and reinfection rates of sexually transmitted diseases among inner-city female adolescents. Patient Educ Couns 1997; 31: 77-81.

167 Cohen DA, Dent C, MacKinnon D, Hahn G. Condoms for men, not women. Results of brief promotion programs. Sex Transm Dis 1992; 19: 245-51.

168 Meyer L, Job-Spira N, Bouyer J, Bouvet E, Spira A. Prevention of sexually transmitted diseases: a randomised community trial. J Epidemiol Community Health 1991; 45: 152-58.

169 Cronan AW. Sexually transmitted diseases: a pilot education programme in Queensland. Community Health Stud 1985, 9; 246-52.[section 6] [section 6.1]

170 Duncan B, Hart G. Sexuality and health: the hidden costs of screening for Chlamydia trachomatis. BMJ 1999; 318: 931-3.

171 Carter, Y, Moss C, Weyman A (editors.). RCGP handbook of sexual health in primary care. RCGP London; 1998.[section 6.1] [section 6.3]

172 Wight D, Abraham C, Scott, S. Towards a psycho-social theoretical framework for sexual health promotion. Health Educ Res 1998; 13: 317-30.

173 Devonshire P, Capewell S, Hillman R. Survey of the level of knowledge of Chlamydia trachomatis genital infection and its consequences in attendees of a genitourinary medicine clinic. Unpublished MPH Thesis; University of Glasgow: Glasgow. 1997.

174 Hunt K, Kitzinger J. Public place, private issue? The public's reaction to the Zero Tolerance campaign against violence against women. In: Bradby H (editor) Defining Violence: understanding the causes and effects of violence. Aldershot: Avebury; 1996.

175 Wight D. Impediments to safer heterosexual sex: a review of research with young people. AIDS Care 1992; 4: 11-23.

176 Rink E. Risk factors for urinary tract symptoms in women: beliefs amongst general practitioners and women and the effect on patient management. Br J Gen Pract 1998; 48: 1155-8.